Location: Dallas, TX
CIK: 0001617201 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $304M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLPG | GALAPAGOS NV | 1,314,898 | $33.03M | 10.9% | $35.00 | — | SPON ADR | 36315X101 |
| MGTX | MEIRAGTX HLDGS PLC | 3,691,546 | $25.03M | 8.2% | $7.18 | -6.5% | COM | G59665102 |
| BBIO | BRIDGEBIO PHARMA INC | 610,000 | $21.09M | 6.9% | $30.67 | +9.9% | COM | 10806X102 |
| JANX | JANUX THERAPEUTICS INC | 689,901 | $18.63M | 6.1% | $42.17 | -10.6% | COM | 47103J105 |
| ROIV | ROIVANT SCIENCES LTD | 1,826,163 | $18.43M | 6.1% | $10.80 | +0.1% | SHS | G76279101 |
| MIRM | MIRUM PHARMACEUTICALS INC | 343,326 | $15.47M | 5.1% | $29.75 | +58.4% | COM | 604749101 |
| KURA | KURA ONCOLOGY INC | 2,078,315 | $13.72M | 4.5% | $11.31 | -31.1% | COM | 50127T109 |
| ADCT | ADC THERAPEUTICS SA | 9,543,004 | $13.46M | 4.4% | $3.21 | -47.1% | SHS | H0036K147 |
| ZYME | ZYMEWORKS INC | 957,229 | $11.4M | 3.7% | $10.24 | +33.2% | COM | 98985Y108 |
| FOLD | AMICUS THERAPEUTICS INC | 1,379,383 | $11.26M | 3.7% | $10.01 | -7.6% | COM | 03152W109 |
| ICLR | ICON PLC | 60,099 | $10.52M | 3.5% | $233.52 | -17.0% | SHS | G4705A100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,480,000 | $9.872M | 3.2% | $14.27 | -30.8% | COM | 77313F106 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 290,000 | $8.793M | 2.9% | $45.33 | -15.9% | COM | 00404A109 |
| ARGX | ARGENX SE | 13,700 | $8.109M | 2.7% | $591.87 | — | SPONSORED ADR | 04016X101 |
| SDGR | SCHRODINGER INC | 385,000 | $7.6M | 2.5% | $21.79 | +3.2% | COM | 80810D103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 609,252 | $7.485M | 2.5% | $20.52 | -31.3% | COM | 87164F105 |
| TECX | TECTONIC THERAPEUTIC INC | 398,885 | $7.064M | 2.3% | $32.59 | 0.0% | COM | 878972108 |
| ISRG | INTUITIVE SURGICAL INC | 14,000 | $6.934M | 2.3% | $553.02 | 0.0% | COM NEW | 46120E602 |
| STTK | SHATTUCK LABS INC | 6,638,935 | $6.308M | 2.1% | $5.19 | -76.3% | COM | 82024L103 |
| ABCL | ABCELLERA BIOLOGICS INC | 2,815,652 | $6.279M | 2.1% | $3.80 | -24.4% | COM | 00288U106 |
| IMVT | IMMUNOVANT INC | 360,000 | $6.152M | 2.0% | $31.01 | -32.5% | COM | 45258J102 |
| PRTA | PROTHENA CORP PLC | 408,122 | $5.051M | 1.7% | $26.88 | -47.4% | SHS | G72800108 |
| LIVN | LIVANOVA PLC | 127,300 | $5M | 1.6% | $47.44 | -5.5% | SHS | G5509L101 |
| HAE | HAEMONETICS CORP MASS | 65,400 | $4.156M | 1.4% | $77.13 | -11.8% | COM | 405024100 |
| — | BLUEPRINT MEDICINES CORP | 36,512 | $3.232M | 1.1% | $90.93 | — | COM | 09627Y109 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 575,136 | $3.054M | 1.0% | $20.33 | -56.6% | COM NEW | 21833P301 |
| CTMX | CYTOMX THERAPEUTICS INC | 3,930,008 | $2.499M | 0.8% | $1.23 | -36.8% | COM | 23284F105 |
| CDNA | CAREDX INC | 136,593 | $2.425M | 0.8% | $23.17 | -7.0% | COM | 14167L103 |
| BHVN | BIOHAVEN LTD | 100,000 | $2.404M | 0.8% | $35.26 | 0.0% | COM | G1110E107 |
| ADUS | ADDUS HOMECARE CORP | 24,045 | $2.378M | 0.8% | $111.21 | 0.0% | COM | 006739106 |
| SGHT | SIGHT SCIENCES INC | 969,287 | $2.326M | 0.8% | $5.64 | -50.0% | COM | 82657M105 |
| ERAS | ERASCA INC | 947,110 | $1.298M | 0.4% | $2.11 | -18.8% | COM | 29479A108 |
| SYRE | SPYRE THERAPEUTICS INC | 74,921 | $1.209M | 0.4% | $29.32 | -29.0% | COM NEW | 00773J202 |
| OKUR | ONKURE THERAPEUTICS INC | 186,570 | $802K | 0.3% | $8.87 | -36.6% | COM CL A | 68277Q105 |
| RNTX | REIN THERAPEUTICS INC | 430,000 | $761K | 0.3% | $3.55 | -40.9% | COM NEW | 00887A204 |
| — | MURAL ONCOLOGY PUB LTD CO | 422,743 | $533K | 0.2% | $5.09 | — | ORD SHS | G63365103 |
| PLRX | PLIANT THERAPEUTICS INC | 334,263 | $451K | 0.1% | $6.07 | 0.0% | COM | 729139105 |
| IMNM | IMMUNOME INC | 23,618 | $159K | 0.1% | $14.65 | -34.5% | COM | 45257U108 |